Taxol-induced cell cycle arrest and apoptosis: Dose-response relationship in lung cancer cells of different wild-type p53 status and under isogenic condition

Cancer Letters

Volumn 165, Issue 2, 2001, Pages 147-153

  Das, Gokul C ^a   Holiday, David ^a   Gallardo, Rafael ^a   Haas, Charles ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

Author keywords

Apoptosis; Cell cycle; G2 M arrest; Isogenic cells; p53; Taxol

Indexed keywords

DNA; PACLITAXEL; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G1 PHASE; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA CONTENT; DRUG EFFICACY; HUMAN; HUMAN CELL; LUNG CARCINOMA; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; DNA; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; G2 PHASE; GENES, P53; HUMANS; LUNG NEOPLASMS; MITOSIS; PACLITAXEL; TUMOR CELLS, CULTURED;

EID: 0035953851     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00404-9     Document Type: Article

References (31)

1. Antimicrotubule agents
2. The current and future prospects of paclitaxel in the treatment of small cell lung cancer
3. Promotion of microtubule assembly in vitro by taxol
4. Taxol stabilizes microtubules in mouse fibroblast cells
5. Mechanism of mitotic block and inhibition of cell proliferation by taxol at low concentrations
6. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (taxol) results in abnormal mitotic exit and apoptotic cell death
7. Paclitaxel inhibits progression of miotic cells to G1 phase by interference with spindle formation without affecting other microtubule functions during anaphase and telophase
8. Taxol-induced bcl-2 phosphorylation and death of prostate cancer cells
9. Mechanism of taxol-induced cell death are concentration dependent
10. Differential regulation of mitogen-activated protein kinases by microtubule binding agents in human breast cancer cells
11. On pushing the outer edge of the outer edge of paclitaxel's dosing envelope
12. WAF-1/CIP is induced in p53-mediated G1 arrest and apoptosis
13. A p53-dependent mouse spindle check point
14. p53 involvement in control of G2 exit of the cell cycle: Role in DNA damage-induced apoptosis
15. p53 controls both the G2/M and the G1 cell cycle checkpoints and mediates growth arrest in human fibroblasts
16. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
17. Inactivation of p53 enhances sensitivity to multiple chemotherapeutic agents
18. Disruption of p53 function sensitizes breast cancer cells to cisplatin and pentoxifyline
19. Loss of normal p53 function confers sensitization to taxol by increasing G2/M arrest and apoptosis
20. p53 and chemosensitivity
21. Micro-tubule active drugs taxol, Vinblastine, and nocodazole increases the level of transcriptionally active p53
22. Taxol induction p21/Waf-1 and p53 requires c-raf 1
23. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate and breast cancer
24. Methods utilized in the study of apoptosis
25. Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity
26. Gene therapy for lung cancer: Enhancement of tumor suppression by a combination of sequential systematic cisplatin and adenovirus mediated gene transfer
27. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus mediated transfer of the wild-type gene
28. Paclitaxel induced cell death: Where the cell cycle and apoptosis come together
29. Characterization of the p53 tumor-suppressor pathway in cell lines of the National Cancer Institute Anticancer Drug Screen and correlations with the growth inhibitory potency of 123 anticancer agents
30. Characterization of the p53-dependent postmitotic checkpoint following spindle disruption
31. p53 and pRb prevent rereplication in response to microtubule inhibitors by mediating a reversible G1 arrest